219 related articles for article (PubMed ID: 17075343)
1. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Rath T; Roderfeld M; Graf J; Wagner S; Vehr AK; Dietrich C; Geier A; Roeb E
Inflamm Bowel Dis; 2006 Nov; 12(11):1025-35. PubMed ID: 17075343
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.
von Lampe B; Barthel B; Coupland SE; Riecken EO; Rosewicz S
Gut; 2000 Jul; 47(1):63-73. PubMed ID: 10861266
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
McKaig BC; McWilliams D; Watson SA; Mahida YR
Am J Pathol; 2003 Apr; 162(4):1355-60. PubMed ID: 12651627
[TBL] [Abstract][Full Text] [Related]
4. Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis.
Rath T; Roderfeld M; Halwe JM; Tschuschner A; Roeb E; Graf J
Scand J Gastroenterol; 2010 Oct; 45(10):1186-96. PubMed ID: 20568971
[TBL] [Abstract][Full Text] [Related]
5. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.
Heuschkel RB; MacDonald TT; Monteleone G; Bajaj-Elliott M; Smith JA; Pender SL
Gut; 2000 Jul; 47(1):57-62. PubMed ID: 10861265
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
8. Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
Piechota-Polanczyk A; Włodarczyk M; Sobolewska-Włodarczyk A; Jonakowski M; Pilarczyk A; Stec-Michalska K; Wiśniewska-Jarosińska M; Fichna J
Dig Dis Sci; 2017 Jun; 62(6):1511-1517. PubMed ID: 28391416
[TBL] [Abstract][Full Text] [Related]
9. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
[TBL] [Abstract][Full Text] [Related]
10. Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
Aust G; Hofmann A; Laue S; Rost A; Köhler T; Scherbaum WA
Thyroid; 1997 Oct; 7(5):713-24. PubMed ID: 9349574
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
[TBL] [Abstract][Full Text] [Related]
12. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.
Kirkegaard T; Hansen A; Bruun E; Brynskov J
Gut; 2004 May; 53(5):701-9. PubMed ID: 15082589
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
Roeb E; Arndt M; Jansen B; Schumpelick V; Matern S
Int J Colorectal Dis; 2004 Nov; 19(6):518-24. PubMed ID: 15103490
[TBL] [Abstract][Full Text] [Related]
14. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases.
Lakatos G; Hritz I; Varga MZ; Juhász M; Miheller P; Cierny G; Tulassay Z; Herszényi L
Dig Dis; 2012; 30(3):289-95. PubMed ID: 22722554
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
Saarialho-Kere UK; Vaalamo M; Puolakkainen P; Airola K; Parks WC; Karjalainen-Lindsberg ML
Am J Pathol; 1996 Feb; 148(2):519-26. PubMed ID: 8579114
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis.
Wang YD; Yan PY
World J Gastroenterol; 2006 Oct; 12(37):6050-3. PubMed ID: 17009408
[TBL] [Abstract][Full Text] [Related]
17. Effect of the anti-tumor necrosis factor-alpha antibody infliximab on the ex vivo mucosal matrix metalloproteinase-proteolytic phenotype in inflammatory bowel disease.
Meijer MJ; Mieremet-Ooms MA; van Duijn W; van der Zon AM; Hanemaaijer R; Verheijen JH; van Hogezand RA; Lamers CB; Verspaget HW
Inflamm Bowel Dis; 2007 Feb; 13(2):200-10. PubMed ID: 17206679
[TBL] [Abstract][Full Text] [Related]
18. Regulation of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and extracellular metalloproteinase inducer by interleukin-17 in human periodontal ligament fibroblasts.
Wu Y; Zhu L; Wei H; Peng B
J Endod; 2013 Jan; 39(1):62-7. PubMed ID: 23228259
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms.
Lv C; Zhao X; Gu H; Huang L; Zhou S; Zhi F
Med Sci Monit; 2016 Dec; 22():4794-4802. PubMed ID: 27926694
[TBL] [Abstract][Full Text] [Related]
20. Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease.
Mäkitalo L; Rintamäki H; Tervahartiala T; Sorsa T; Kolho KL
Scand J Gastroenterol; 2012 Jul; 47(7):785-94. PubMed ID: 22519363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
